A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

NCT05905133 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
360
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Connect Biopharm LLC